About Ixazomib Citrate
Class: | Proteasome inhibitor
Use: | Treatment of multiple myeloma in combination with lenalidomide and dexamethasone in patients who have received at least one prior therapy
Adult dose: | 4 mg orally once weekly on days 1, 8, and 15 of a 28-day cycle; may be adjusted based on tolerability
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Diarrhea, constipation, nausea, fatigue, peripheral neuropathy, thrombocytopenia, anemia
Contraindications:
Drug Class
Proteasome inhibitor
Uses & Indications
Treatment of multiple myeloma in combination with lenalidomide and dexamethasone in patients who have received at least one prior therapy
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: Takeda Pharma A/S, DENMARK
Package Size
3s
Price & Supplier
Price in UAE: AED 46336.00
Dosage Information
Adult Dose
4 mg orally once weekly on days 1, 8, and 15 of a 28-day cycle; may be adjusted based on tolerability
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Diarrhea, constipation, nausea, fatigue, peripheral neuropathy, thrombocytopenia, anemia
Contraindications & Precautions
Hypersensitivity to ixazomib or any component of the formulation; pregnancy (Category D)
Important Warnings
Risk of thrombocytopenia, peripheral neuropathy, and gastrointestinal toxicity; monitor blood counts regularly; avoid use in pregnancy and breastfeeding; may cause fetal harm
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.